...
首页> 外文期刊>Journal of clinical rheumatology >Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment.
【24h】

Subacute thyroiditis presenting as fever of unknown origin in a patient with rheumatoid arthritis under etanercept treatment.

机译:在依那西普治疗下的类风湿关节炎患者中,亚急性甲状腺炎表现为不明原因的发烧。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In September 2007, a 50-year-old woman presented with unexplained fever of 2 weeks duration. The patient had erosive rheumatoid arthritis for 8 years, which was initially resistant to treatment with corticosteroids, hydroxychloroquine, and methotrexate. For the past 4 years, she was being treated successfully with a combination of an anti-tumor necrosis factor (TNF) agent (etanercept, 50 mg/ wk), low dose prednisolone (5 mg/d), and hydroxychloroquine. One year after treatment initiation with etanercept, she developed discoid lupus (facial skin rash, positive antinuclear antibodies, positive skin biopsy), without evidence of systemic involvement that was treated successfully with local corticosteroids, without discontinuing etanercept.
机译:2007年9月,一名50岁的妇女出现了持续2周的原因不明的发烧。该患者患有风湿性风湿性关节炎长达8年,最初对皮质类固醇,羟氯喹和甲氨蝶呤治疗无效。在过去的四年中,她已成功接受抗肿瘤坏死因子(TNF)药物(etanercept,50 mg / wk),低剂量泼尼松龙(5 mg / d)和羟氯喹的联合治疗。在开始使用依那西普治疗后的一年,她出现了盘状狼疮(面部皮疹,抗核抗体阳性,活组织检查阳性),没有证据表明全身性受累已成功用局部皮质类固醇治疗,而没有中断依那西普。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号